| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 19 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 19 |
| 3 | PREDNISONE | 15 |
| 4 | FLUDARABINE PHOSPHATE | 14 |
| 5 | AZACITIDINE | 10 |
| 6 | LENALIDOMIDE | 10 |
| 7 | METHOTREXATE SODIUM | 9 |
| 8 | CLADRIBINE | 7 |
| 9 | DEXAMETHASONE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 3 | 0.0020 |
| 1 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 2 | CLADRIBINE | 7 | 0.0007 |
| 3 | VORINOSTAT | 1 | 0.0005 |
| 4 | FLUDARABINE PHOSPHATE | 14 | 0.0004 |
| 5 | AZACITIDINE | 10 | 0.0003 |
| 6 | PAMIDRONATE DISODIUM | 1 | 0.0003 |
| 7 | BUSULFAN | 4 | 0.0003 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 9 | ELOTUZUMAB | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22 |
| 1 | Alkylating Drug [EPC] | 20 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| 3 | Purine Antimetabolite [EPC] | 11 |
| 4 | Thalidomide Analog [EPC] | 10 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 7 |
| 6 | Microtubule Inhibitor [EPC] | 7 |
| 7 | Kinase Inhibitor [EPC] | 6 |
| 8 | Platinum-based Drug [EPC] | 5 |
| 9 | Azole Antifungal [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 1 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 6 | Antimalarial [EPC] | 1 | 0.0001 |
| 7 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 20 | 0.0001 |
| 9 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |